nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2D6—endogenous depression	0.803	1	CbGaD
Irbesartan—JUN—brainstem—endogenous depression	0.00365	0.0412	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—endogenous depression	0.00361	0.0407	CbGeAlD
Irbesartan—EDNRA—adrenal cortex—endogenous depression	0.00358	0.0404	CbGeAlD
Irbesartan—JUN—forebrain—endogenous depression	0.00353	0.0398	CbGeAlD
Irbesartan—JUN—adrenal cortex—endogenous depression	0.00327	0.0368	CbGeAlD
Irbesartan—JUN—cardiovascular system—endogenous depression	0.00298	0.0336	CbGeAlD
Irbesartan—EDNRA—pituitary gland—endogenous depression	0.00289	0.0326	CbGeAlD
Irbesartan—AGTR1—forebrain—endogenous depression	0.00266	0.0299	CbGeAlD
Irbesartan—JUN—pituitary gland—endogenous depression	0.00264	0.0298	CbGeAlD
Irbesartan—EDNRA—adrenal gland—endogenous depression	0.00259	0.0291	CbGeAlD
Irbesartan—EDNRA—midbrain—endogenous depression	0.00255	0.0288	CbGeAlD
Irbesartan—EDNRA—thyroid gland—endogenous depression	0.0025	0.0281	CbGeAlD
Irbesartan—AGTR1—adrenal cortex—endogenous depression	0.00246	0.0277	CbGeAlD
Irbesartan—JUN—adrenal gland—endogenous depression	0.00236	0.0266	CbGeAlD
Irbesartan—JUN—midbrain—endogenous depression	0.00233	0.0263	CbGeAlD
Irbesartan—JUN—thyroid gland—endogenous depression	0.00228	0.0257	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—endogenous depression	0.00225	0.0253	CbGeAlD
Irbesartan—JUN—endocrine gland—endogenous depression	0.00205	0.0231	CbGeAlD
Irbesartan—AGTR1—pituitary gland—endogenous depression	0.00199	0.0224	CbGeAlD
Irbesartan—JUN—nervous system—endogenous depression	0.00191	0.0216	CbGeAlD
Irbesartan—JUN—central nervous system—endogenous depression	0.00184	0.0208	CbGeAlD
Irbesartan—JUN—cerebellum—endogenous depression	0.0018	0.0203	CbGeAlD
Irbesartan—AGTR1—adrenal gland—endogenous depression	0.00178	0.02	CbGeAlD
Irbesartan—AGTR1—thyroid gland—endogenous depression	0.00171	0.0193	CbGeAlD
Irbesartan—EDNRA—brain—endogenous depression	0.0016	0.0181	CbGeAlD
Irbesartan—AGTR1—endocrine gland—endogenous depression	0.00154	0.0174	CbGeAlD
Irbesartan—JUN—brain—endogenous depression	0.00146	0.0165	CbGeAlD
Irbesartan—AGTR1—nervous system—endogenous depression	0.00144	0.0163	CbGeAlD
Irbesartan—AGTR1—central nervous system—endogenous depression	0.00139	0.0156	CbGeAlD
Irbesartan—PTGS1—forebrain—endogenous depression	0.00117	0.0132	CbGeAlD
Irbesartan—AGTR1—brain—endogenous depression	0.0011	0.0124	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—endogenous depression	0.00108	0.0122	CbGeAlD
Irbesartan—CYP2C8—pituitary gland—endogenous depression	0.00108	0.0122	CbGeAlD
Irbesartan—CYP2D6—brainstem—endogenous depression	0.000995	0.0112	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—endogenous depression	0.000988	0.0111	CbGeAlD
Irbesartan—CYP2D6—forebrain—endogenous depression	0.00096	0.0108	CbGeAlD
Irbesartan—PTGS1—pituitary gland—endogenous depression	0.000874	0.00985	CbGeAlD
Irbesartan—CYP1A2—thyroid gland—endogenous depression	0.00087	0.0098	CbGeAlD
Irbesartan—CYP2C8—endocrine gland—endogenous depression	0.000835	0.00941	CbGeAlD
Irbesartan—CYP1A2—endocrine gland—endogenous depression	0.000782	0.00881	CbGeAlD
Irbesartan—PTGS1—adrenal gland—endogenous depression	0.000781	0.0088	CbGeAlD
Irbesartan—PTGS1—thyroid gland—endogenous depression	0.000754	0.00849	CbGeAlD
Irbesartan—CYP2C9—endocrine gland—endogenous depression	0.000742	0.00836	CbGeAlD
Irbesartan—PTGS1—endocrine gland—endogenous depression	0.000677	0.00763	CbGeAlD
Irbesartan—PTGS1—nervous system—endogenous depression	0.000634	0.00714	CbGeAlD
Irbesartan—PTGS1—central nervous system—endogenous depression	0.00061	0.00688	CbGeAlD
Irbesartan—CYP2C8—brain—endogenous depression	0.000598	0.00673	CbGeAlD
Irbesartan—CYP3A4—endocrine gland—endogenous depression	0.000566	0.00638	CbGeAlD
Irbesartan—CYP2D6—endocrine gland—endogenous depression	0.000557	0.00627	CbGeAlD
Irbesartan—CYP3A4—nervous system—endogenous depression	0.00053	0.00597	CbGeAlD
Irbesartan—JUN—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000523	0.00484	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000523	0.00484	CbGpPWpGaD
Irbesartan—CYP2D6—nervous system—endogenous depression	0.000521	0.00587	CbGeAlD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000511	0.00473	CbGpPWpGaD
Irbesartan—CYP3A4—central nervous system—endogenous depression	0.00051	0.00575	CbGeAlD
Irbesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000507	0.00469	CbGpPWpGaD
Irbesartan—CYP2D6—central nervous system—endogenous depression	0.000502	0.00565	CbGeAlD
Irbesartan—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.0005	0.00463	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—ADM—endogenous depression	0.0005	0.00462	CbGpPWpGaD
Irbesartan—CYP2D6—cerebellum—endogenous depression	0.00049	0.00553	CbGeAlD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000485	0.00449	CbGpPWpGaD
Irbesartan—PTGS1—brain—endogenous depression	0.000485	0.00546	CbGeAlD
Irbesartan—PTGS1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000478	0.00443	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—MAOA—endogenous depression	0.000474	0.00439	CbGpPWpGaD
Irbesartan—EDNRA—G alpha (q) signalling events—HTR2A—endogenous depression	0.000473	0.00438	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000468	0.00433	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—CRH—endogenous depression	0.000459	0.00425	CbGpPWpGaD
Irbesartan—UGT1A3—Biological oxidations—COMT—endogenous depression	0.000454	0.0042	CbGpPWpGaD
Irbesartan—UGT1A3—Biological oxidations—MAOA—endogenous depression	0.000451	0.00418	CbGpPWpGaD
Irbesartan—UGT1A3—Metapathway biotransformation—COMT—endogenous depression	0.000448	0.00415	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000448	0.00414	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000431	0.00399	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—POMC—endogenous depression	0.000429	0.00397	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—SLC6A4—endogenous depression	0.000427	0.00395	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000423	0.00392	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—OXT—endogenous depression	0.000419	0.00387	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CRH—endogenous depression	0.000419	0.00387	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000415	0.00384	CbGpPWpGaD
Irbesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000412	0.00382	CbGpPWpGaD
Irbesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000411	0.0038	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00041	0.00379	CbGpPWpGaD
Irbesartan—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000407	0.00376	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—BDNF—endogenous depression	0.000405	0.00375	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR1A—endogenous depression	0.000403	0.00373	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000401	0.00371	CbGpPWpGaD
Irbesartan—CYP2D6—brain—endogenous depression	0.000398	0.00449	CbGeAlD
Irbesartan—JUN—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000394	0.00364	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—ADM—endogenous depression	0.000392	0.00363	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR2C—endogenous depression	0.000389	0.0036	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00038	0.00351	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—HTR7—endogenous depression	0.000374	0.00346	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—POMC—endogenous depression	0.000373	0.00345	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—HTR2A—endogenous depression	0.000372	0.00344	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000366	0.00339	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000363	0.00336	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—BDNF—endogenous depression	0.000358	0.00331	CbGpPWpGaD
Irbesartan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000352	0.00326	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000351	0.00325	CbGpPWpGaD
Irbesartan—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000348	0.00322	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR7—endogenous depression	0.000341	0.00315	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—CYP2D6—endogenous depression	0.000338	0.00313	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000335	0.0031	CbGpPWpGaD
Irbesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000334	0.00309	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000332	0.00307	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—OXT—endogenous depression	0.000329	0.00304	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CRH—endogenous depression	0.000329	0.00304	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000323	0.00299	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000321	0.00297	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR1A—endogenous depression	0.000316	0.00293	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000314	0.0029	CbGpPWpGaD
Irbesartan—PTGS1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000311	0.00288	CbGpPWpGaD
Irbesartan—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000309	0.00286	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR2C—endogenous depression	0.000305	0.00283	CbGpPWpGaD
Irbesartan—UGT1A3—Biological oxidations—POMC—endogenous depression	0.000294	0.00272	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—POMC—endogenous depression	0.000293	0.00271	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000287	0.00266	CbGpPWpGaD
Irbesartan—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000286	0.00264	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—ADM—endogenous depression	0.000282	0.00261	CbGpPWpGaD
Irbesartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000272	0.00252	CbGpPWpGaD
Irbesartan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000268	0.00248	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR7—endogenous depression	0.000268	0.00248	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—WASF2—endogenous depression	0.000258	0.00239	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—ADM—endogenous depression	0.000256	0.00237	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—COMT—endogenous depression	0.000256	0.00237	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—MAOA—endogenous depression	0.000254	0.00235	CbGpPWpGaD
Irbesartan—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000254	0.00235	CbGpPWpGaD
Irbesartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000252	0.00233	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00025	0.00232	CbGpPWpGaD
Irbesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000248	0.0023	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—WASF1—endogenous depression	0.000247	0.00229	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000246	0.00228	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR2A—endogenous depression	0.000239	0.00221	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CRH—endogenous depression	0.000237	0.00219	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—OXT—endogenous depression	0.000237	0.00219	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR1A—endogenous depression	0.000228	0.00211	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—ADM—endogenous depression	0.000222	0.00205	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00022	0.00204	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR2C—endogenous depression	0.00022	0.00204	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.000218	0.00202	CbGpPWpGaD
Irbesartan—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.000215	0.00199	CbGpPWpGaD
Irbesartan—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000215	0.00199	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CRH—endogenous depression	0.000215	0.00199	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—OXT—endogenous depression	0.000215	0.00199	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR1A—endogenous depression	0.000207	0.00191	CbGpPWpGaD
Irbesartan—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000204	0.00189	CbGpPWpGaD
Irbesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000202	0.00187	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—ADM—endogenous depression	0.000201	0.00186	CbGpPWpGaD
Irbesartan—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000201	0.00186	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR2C—endogenous depression	0.0002	0.00185	CbGpPWpGaD
Irbesartan—CYP1A2—Phase II conjugation—COMT—endogenous depression	0.000197	0.00182	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.000197	0.00182	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR7—endogenous depression	0.000193	0.00178	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—POMC—endogenous depression	0.000191	0.00176	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR2A—endogenous depression	0.000187	0.00173	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—OXT—endogenous depression	0.000186	0.00172	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CRH—endogenous depression	0.000186	0.00172	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR1A—endogenous depression	0.000179	0.00165	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.000178	0.00164	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.000175	0.00162	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR7—endogenous depression	0.000175	0.00162	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR2C—endogenous depression	0.000173	0.0016	CbGpPWpGaD
Irbesartan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000173	0.0016	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—TPH1—endogenous depression	0.000169	0.00157	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—OXT—endogenous depression	0.000169	0.00156	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CRH—endogenous depression	0.000169	0.00156	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000166	0.00153	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—WASF2—endogenous depression	0.000166	0.00153	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—POMC—endogenous depression	0.000165	0.00153	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—COMT—endogenous depression	0.000165	0.00153	CbGpPWpGaD
Irbesartan—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000165	0.00153	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.000164	0.00152	CbGpPWpGaD
Irbesartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000164	0.00152	CbGpPWpGaD
Irbesartan—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.000163	0.00151	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR1A—endogenous depression	0.000162	0.0015	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—WASF1—endogenous depression	0.000159	0.00147	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR2C—endogenous depression	0.000157	0.00145	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—CYP2D6—endogenous depression	0.000152	0.0014	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ADM—endogenous depression	0.000151	0.0014	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR7—endogenous depression	0.000151	0.0014	CbGpPWpGaD
Irbesartan—JUN—Immune System—WASF2—endogenous depression	0.00015	0.00139	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—POMC—endogenous depression	0.00015	0.00138	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—CYP2D6—endogenous depression	0.00015	0.00138	CbGpPWpGaD
Irbesartan—JUN—Immune System—WASF1—endogenous depression	0.000144	0.00133	CbGpPWpGaD
Irbesartan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00014	0.00129	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR7—endogenous depression	0.000137	0.00127	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—COMT—endogenous depression	0.000136	0.00126	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR2A—endogenous depression	0.000135	0.00125	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—MAOA—endogenous depression	0.000135	0.00125	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—COMT—endogenous depression	0.000135	0.00125	CbGpPWpGaD
Irbesartan—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	0.000134	0.00124	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—MAOA—endogenous depression	0.000134	0.00124	CbGpPWpGaD
Irbesartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000133	0.00123	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	0.000133	0.00123	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—WASF2—endogenous depression	0.00013	0.0012	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—TPH2—endogenous depression	0.000128	0.00119	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CACNB2—endogenous depression	0.000128	0.00119	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CRH—endogenous depression	0.000127	0.00117	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—OXT—endogenous depression	0.000127	0.00117	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—DPYD—endogenous depression	0.000126	0.00117	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—WASF1—endogenous depression	0.000125	0.00115	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR2A—endogenous depression	0.000123	0.00113	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR1A—endogenous depression	0.000122	0.00113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ADM—endogenous depression	0.000119	0.0011	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR2C—endogenous depression	0.000118	0.00109	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CACNA1C—endogenous depression	0.000117	0.00109	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.000117	0.00108	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000115	0.00107	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—COMT—endogenous depression	0.000115	0.00106	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—MAOA—endogenous depression	0.000114	0.00106	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—COMT—endogenous depression	0.000113	0.00105	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000108	0.000999	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—POMC—endogenous depression	0.000108	0.000997	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—POMC—endogenous depression	0.000107	0.000989	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR2A—endogenous depression	0.000106	0.00098	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR7—endogenous depression	0.000103	0.000956	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP2D6—endogenous depression	0.000103	0.000949	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—OXT—endogenous depression	9.96e-05	0.000922	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CRH—endogenous depression	9.96e-05	0.000922	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—POMC—endogenous depression	9.79e-05	0.000906	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—WASF2—endogenous depression	9.71e-05	0.000898	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR2A—endogenous depression	9.62e-05	0.00089	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR1A—endogenous depression	9.59e-05	0.000887	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TPH1—endogenous depression	9.53e-05	0.000882	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—WASF1—endogenous depression	9.31e-05	0.000861	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2C—endogenous depression	9.26e-05	0.000857	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADM—endogenous depression	8.88e-05	0.000822	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—COMT—endogenous depression	8.87e-05	0.000821	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—MAOA—endogenous depression	8.81e-05	0.000815	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—POMC—endogenous depression	8.77e-05	0.000812	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	8.75e-05	0.00081	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—POMC—endogenous depression	8.7e-05	0.000805	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—POMC—endogenous depression	8.46e-05	0.000783	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR7—endogenous depression	8.11e-05	0.00075	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—COMT—endogenous depression	7.77e-05	0.000719	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MAOA—endogenous depression	7.72e-05	0.000714	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—POMC—endogenous depression	7.68e-05	0.000711	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—OXT—endogenous depression	7.44e-05	0.000689	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CRH—endogenous depression	7.44e-05	0.000689	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—POMC—endogenous depression	7.43e-05	0.000688	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR2A—endogenous depression	7.24e-05	0.00067	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TPH2—endogenous depression	7.22e-05	0.000669	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CACNB2—endogenous depression	7.22e-05	0.000669	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR1A—endogenous depression	7.16e-05	0.000663	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DPYD—endogenous depression	7.11e-05	0.000658	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2C—endogenous depression	6.92e-05	0.00064	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CACNA1C—endogenous depression	6.61e-05	0.000611	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	6.35e-05	0.000588	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TPH1—endogenous depression	6.16e-05	0.00057	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR7—endogenous depression	6.06e-05	0.000561	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—endogenous depression	5.78e-05	0.000535	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2D6—endogenous depression	5.78e-05	0.000534	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—endogenous depression	5.74e-05	0.000531	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2A—endogenous depression	5.68e-05	0.000526	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TPH1—endogenous depression	5.06e-05	0.000468	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—endogenous depression	5.02e-05	0.000465	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TPH1—endogenous depression	5.01e-05	0.000464	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TPH2—endogenous depression	4.67e-05	0.000432	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CACNB2—endogenous depression	4.67e-05	0.000432	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DPYD—endogenous depression	4.59e-05	0.000425	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—endogenous depression	4.54e-05	0.00042	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—COMT—endogenous depression	4.38e-05	0.000405	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOA—endogenous depression	4.35e-05	0.000402	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TPH1—endogenous depression	4.28e-05	0.000396	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CACNA1C—endogenous depression	4.27e-05	0.000395	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—endogenous depression	4.24e-05	0.000393	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	4.1e-05	0.00038	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TPH2—endogenous depression	3.83e-05	0.000354	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNB2—endogenous depression	3.83e-05	0.000354	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TPH2—endogenous depression	3.8e-05	0.000351	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNB2—endogenous depression	3.8e-05	0.000351	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DPYD—endogenous depression	3.77e-05	0.000349	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DPYD—endogenous depression	3.74e-05	0.000346	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2D6—endogenous depression	3.73e-05	0.000345	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNA1C—endogenous depression	3.5e-05	0.000324	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNA1C—endogenous depression	3.47e-05	0.000321	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—endogenous depression	3.39e-05	0.000314	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	3.34e-05	0.000309	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TPH1—endogenous depression	3.31e-05	0.000306	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TPH2—endogenous depression	3.25e-05	0.0003	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNB2—endogenous depression	3.25e-05	0.0003	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DPYD—endogenous depression	3.19e-05	0.000295	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2D6—endogenous depression	3.04e-05	0.000281	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNA1C—endogenous depression	2.97e-05	0.000275	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.85e-05	0.000264	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—endogenous depression	2.83e-05	0.000262	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—COMT—endogenous depression	2.83e-05	0.000262	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOA—endogenous depression	2.81e-05	0.00026	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2D6—endogenous depression	2.59e-05	0.00024	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNB2—endogenous depression	2.5e-05	0.000232	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TPH2—endogenous depression	2.5e-05	0.000232	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DPYD—endogenous depression	2.46e-05	0.000228	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—COMT—endogenous depression	2.32e-05	0.000215	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOA—endogenous depression	2.3e-05	0.000213	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—COMT—endogenous depression	2.3e-05	0.000213	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA1C—endogenous depression	2.29e-05	0.000212	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOA—endogenous depression	2.28e-05	0.000211	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2D6—endogenous depression	2e-05	0.000185	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—COMT—endogenous depression	1.97e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOA—endogenous depression	1.95e-05	0.000181	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—endogenous depression	1.83e-05	0.000169	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—COMT—endogenous depression	1.52e-05	0.00014	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOA—endogenous depression	1.51e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—endogenous depression	1.5e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—endogenous depression	1.49e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—endogenous depression	1.27e-05	0.000118	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—endogenous depression	9.81e-06	9.08e-05	CbGpPWpGaD
